Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts from ‘January, 2009’

Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent

HAMILTON, Bermuda, Jan. 30 (HSMN NewsFeed) — Warner Chilcott Limited (Nasdaq: WCRX ) announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a lawsuit against Actavis Elizabeth LLC ("Acta…
Biopharmaceuticals, Litigation
Warner Chilcott, Mayne Pharma, Actavis, DORYX, tetracycline, antibiotic

FDA Approves KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD

First Proton Pump Inhibitor (PPI) With a Dual Delayed Release(TM) (DDR) Formulation DEERFIELD, IL and OSAKA, JAPAN–Jan 30, 2009 — Takeda Medical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today …
Biopharmaceuticals, Gastroenterology, FDA
Takeda Pharmaceutical, KAPIDEX, dexlansoprazole, Gastroesophageal Reflux Disease

Special Committee of Genentech Board of Directors Responds to Roche’s Announced Intention to Commence a Tender Offer

South San Francisco, Calif., January 30, 2009 - (HSMN NewsFeed) - The special committee of the Board of Directors of Genentech, Inc. (NYSE: DNA) today urged shareholders to take no action at this time with respect to the announcement by Roche that it int…
Biopharmaceuticals, Mergers & Acquisitions
Genentech, Roche Group

Teva Announces Approval of Generic Risperdal(R) Oral Solution

JERUSALEM, Jan 30, 2009 - (HSMN NewsFeed) - Teva Pharma Industries Ltd. (Nasdaq: TEVA ) announced today that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) to market its ge…
Biopharmacueticals, Generics, FDA
Teva Clinical laboratory, Risperidone, Risperdal, Janssen, antipsychotic

ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Clinical Corporation

CHELMSFORD, Mass.–(HSMN NewsFeed)–ZOLL Pharma Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it had filed a lawsuit against Alsius Corporation (Nasdaq: ALUS ) and Alsius Medica…
Devices, Litigation
ZOLL Clinical, Alsius, Alsius Medical

Mylan Receives FDA Approval for First-to-File Generic Depakote(R) ER

Company will have 180 days of product management exclusivity on the Five hundred mg strength PITTSBURGH, Jan. Thirty (HSMN NewsFeed) — Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food a…
Biopharmacueticals, Generics, FDA
Mylan, Mylan Pharmaceuticals, Divalproex, Abbott, Depakote

AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)

First Diagnostic Test for Identifying E. coli and P. aeruginosa Directly from Positive Blood Cultures PNA FISH to Provide Critical Results 24-48 Hours Sooner Than Conventional Methods, Helping Clinicians to Improve Care and Outcomes for One hundred,000 Patients…
Diagnostics, FDA
AdvanDx, E. coli, P. aeruginosa, PNA FISH,

Cook Pharma unveils the Advance Drug-Eluting Balloon and Other Cutting-Edge Devices to Advance Leg Therapy at the ISET 2009 International Symposium on Endovascular Therapy

Event was punctuated by several product introductions and a live case demonstration of percutaneous transluminal angioplasty using a drug-eluting balloon BLOOMINGTON, Ind., Jan 30, 2009 - (HSMN NewsFeed) - In a live case transmitted from The Heart Cente…
Devices, Interventional
Cook Medical, Advance PTX, drug-eluting balloon, paclitaxel

Neurosurgery Journal Issues Supplement Dedicated to CyberKnife Radiosurgery Experience

Supplement Features Fifteen Peer Reviewed Papers Describing CyberKnife Radiosurgery for Brain and Spine Applications SUNNYVALE, Calif., Jan. 30 (HSMN NewsFeed) — Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced…
Devices, Neurosurgery, Oncology
Accuray, CyberKnife, robotic radiosurgery, radiosurgery

SonoSite Introduces Powerful New Turbo Technology for S Series(TM)

New Color Flow, New Remote Control, New Workflow Integration Capabilities SonoSite Demonstrating SonoGT at SCCM Congress in Nashville, February 1-3. BOTHELL, WA- January 30, 2009 - (HSMN NewsFeed) - SonoSite, Inc. (Nasdaq:SONO), the world leader and …
Devices
SonoSite, hand-carried ultrasound, SonoGT